Prohibition PartnersPATENT RACES: THE RUSH TO TRADEMARK NATUREThe race to patent intellectual property is a key mark of any emerging market, with patents widely recognised as the most viable way of…May 28, 2019May 28, 2019
Prohibition PartnersThree Things We Learned From The Asian Cannabis Report™Asia’s medical cannabis market will be worth over US$5.8 billion by 2024 if a number of key markets introduce reform in the medium term…May 14, 2019May 14, 2019
Prohibition PartnersSOUTH AFRICAN GOVERNMENT HINTS AT COMPROMISE OVER CANNABIS DEADLOCKIn September 2018, the Constitutional Courts of South Africa legalised the private use of recreational cannabis. The move went against…Apr 10, 2019Apr 10, 2019
Prohibition PartnersMEDICAL CANNABIS IS NOW LEGAL IN THE UK, BUT WHAT CAN WE EXPECT?Medical cannabis is officially available in the UK today via prescription and millions of patients, who suffer from registered conditions…Mar 4, 2019Mar 4, 2019
Prohibition PartnersFOUR KEY LEARNINGS FROM CANNABIS EUROPA PARISOn Friday 8th February, Cannabis Europa Paris brought together leading voices on medical cannabis from the worlds of politics…Feb 28, 2019Feb 28, 2019
Prohibition PartnersGREEK MARKET YET TO DELIVER AS CANNABIS FIRMS REMAIN STUCK IN THE WEEDSGreece’s government has been busy approving the first wave of licences for companies wanting to grow medicinal cannabis in the Hellenic…Feb 22, 20191Feb 22, 20191
Prohibition PartnersECH CREATES HISTORIC MILESTONE AS FIRST CANNABIS-BASED MEDICAL SHIPMENT ARRIVES FOR UK PATIENTSEuropean Cannabis Holdings (ECH), Grow Biotech, and IPS Specials have created a historic milestone by importing the first bulk shipment of…Feb 15, 20191Feb 15, 20191
Prohibition PartnersUK MEDICINAL CANNABIS USE HAMPERED BY LACK OF DOCTOR TRAININGThe European Cannabis Report™ 4th Edition is the most extensive review to date of the European cannabis industry. It examines legislation…Feb 13, 2019Feb 13, 2019